ZombieHealthcare
What Happened to BridgeBio Oncology Therapeutics?
Ticker: HLXBSPAC Year: 2024
Return
0.0%
Current Price
â
Peak Price
â
Trust Size
$448M
Summary
BridgeBio Oncology Therapeutics, Inc. (HLXB) filed its S-1 registration in 2024. The company remains actively traded with 131 SEC filings on record.
What Happened
BridgeBio Oncology Therapeutics, Inc. entered the SPAC market in 2024 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
SEC records show 131 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2024-02-07
S-1 Registration Filed